NCT02025049View on ClinicalTrials.gov

DP-b99 in the Treatment of Acute High-risk Pancreatitis

PHASE2TerminatedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Pancreatitis
Interventions
DRUG

DP-b99

DP-b99 is a lipophilic analog of the divalent metal ion chelator O,O'-Bis(2-aminophenyl) ethyleneglycol-N,N,N',N'-tetraacetic acid (BAPTA)

DRUG

Placebo

mannitol-based DP-b99 look-alike

Trial Locations (1)

62500

The University Hospital Brno, Gastroenterology Clinic, Brno

Sponsors

Lead Sponsor

D-Pharm Ltd.
All Listed Sponsors
lead

D-Pharm Ltd.

INDUSTRY